ZytoMax is now the exclusive distributor of AmoyDx® products in Switzerland
We are delighted to inform you that due to the positive customer response, the molecular diagnostic products of our partner AmoyDx® are now available to our customers in Switzerland through ZytoMax Schweiz GmbH, a sister company of Zytomed Systems GmbH.
AmoyDx® is a research and development-based diagnostics company with over 1000 employees that focuses on molecular diagnostics for oncological precision medicine. The primarily CE/IVD labeled qPCR and NGS products have proven to be of excellent quality and reliability, as confirmed by numerous successful external proficiency tests conducted by our customers. Furthermore, our product and laboratory team are happy to offer advice and active support during the introduction and establishment of the products.
If you are interested, please do not hesitate to contact your local contact at ZytoMax Schweiz GmbH, via e-mail at info@zytomax.ch or phone at +41 79 965 68 67.
Further topics
New NGS-Assay for HRD determination
The AmoyDx® HRD Complete Panel is an advanced development of the AmoyDx® HRD Focus Panel, which is already established in many laboratories for determining homologous recombination deficiency (HRD).
News about the IVDR
The IVDR, in force since May 26, 2022, represents a turning point in the EU-wide harmonization of patient safety. At the same time, it places high demands on us as manufacturers and on you as a user of in vitro diagnostic medical devices to implement the new regulation. We would like to meet this challenge together with you for the benefit of your patients. It is important to us to certify our portfolio of diagnostic solutions in compliance with the IVDR in due time. Therefore, we would like to keep you informed about our progress with the implementation of the IVDR.
